Anaes · Volatile & inhalational agents
Xenon
Also known as Xe (element 54) · Noble gas anaesthetic · Inert gas anaesthetic · Lowest blood-gas coefficient agent · NMDA-antagonist inhalational agent
Xenon (Xe, element 54) is an inert noble-gas inhalational anaesthetic whose blood-gas partition coefficient of 0.115 is the LOWEST of any agent, giving extremely rapid onset and offset and clear emergence (Baima 2026; Chen 2026). Its MAC is around 71 percent (about 63 percent in the elderly), so it is a weaker anaesthetic than the halogenated volatiles and is given at high inspired concentrations. It is completely inert, not metabolised, with no toxic metabolites; it does not trigger malignant hyperthermia; and it is neither a greenhouse gas nor ozone-depleting. It is haemodynamically very stable, with minimal myocardial depression and no catecholamine sensitisation, making it useful in cardiac disease and the elderly (Hendrix 2026). As an NMDA receptor antagonist it provides analgesia (Ma 2025), and through NMDA antagonism, two-pore-domain potassium-channel (TREK) activation and preconditioning it is neuroprotective and cardioprotective — studied in neonatal hypoxic-ischaemic encephalopathy with cooling, cardiac arrest, traumatic brain injury and myocardial preservation (Chen 2026; Ponomarev 2025; Zamora 2026; Sienel 2026). The main limitations are COST and SCARCITY: xenon is a trace atmospheric gas extracted by fractional distillation of liquid air, expensive, and needs a specialised low-flow closed-circuit delivery system.
Practise this topic
On this page & tools
Your progress
Saved locally on this device.
12 MCQs with explanations
Target exams
Red flags
Meet the patient
A colleague asks you in a viva: "Describe the ideal inhalational anaesthetic." You describe a gas that goes in and out faster than anything else, is inert with zero toxicity, does not trigger malignant hyperthermia, keeps the heart and brain stable, and is environmentally benign. The examiner nods — that agent exists. It is xenon.[1]
Then the examiner asks why you do not use it every day. The answer is not pharmacology — it is economics. Xenon is a trace atmospheric gas, extracted by fractional distillation of liquid air, and it requires a specialised closed-circuit delivery system. Cost and scarcity, not toxicity, keep it a specialist niche.[1][4]
You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the Anaesthesia fellowship atlas.
References7Show ledgerHide ledger
- [1]Baima T, et al. Xenon anesthesia: shedding light on brain dynamics and clinical niches Curr Opin Anaesthesiol, 2026.PMID 42054173
- [2]Chen Q, et al. Noble gases xenon and argon: from cellular signalling mechanisms to organoprotection and clinical applications J Transl Med, 2026.PMID 41803953
- [3]Ponomarev A, et al. Improved Rat Heart Preservation Using High-Pressure Gaseous Perfusion with Oxygen-Xenon Mixture Pathophysiology, 2025.PMID 41283472
- [4]Hendrix JM, et al. Anesthesia Inhalation Agents and Their Cardiovascular Effects 2026.PMID 31082134
- [5]Ma K, et al. Effects of Adjunct Analgesics and Novel Anesthetic Agents on Intraoperative Neuromonitoring: A Scoping Review Anesth Analg, 2026.PMID 42133452
- [6]Zamora EL, et al. Anesthetic Neuroprotection Based on Ion-Channel-Modulating Drugs in Acute Traumatic Brain Injury Cureus, 2026.PMID 41970094
- [7]Sienel RI, et al. Medicinal gases for treating central nervous system injuries Adv Drug Deliv Rev, 2026.PMID 41579968